Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid
✍ Scribed by M. Saeed Sheikh; Zhi-Ming Shao; Jian-Chyi Chen; Arif Hussain; Anton M. Jetten; Joseph A. Fontana
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 968 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
We and others have shown previously that retinoic acid (RA) selectively inhibits the growth of estrogen receptor (ER)-positive human breast carcinoma (HBC) cells and ER-negative cells are refractory to RA inhibition o f growth. The ER-negative cells inherently express lower levels of RARa and retinoic acid response element (RARE)-mediated RA-induced CAT activity. In this study we report that when ER-negative MDA-MB-231 cells were transfectecl with the ER gene they not only expressed higher levels of RARa and RARE-mediated RA-induced CAT gene expression but their growth was now inhibited by RA. Estrogen enhanced RARa gene expression not only in established ER-positive cell lines but also in ER-transfected MDA-MB-231 cells. The estrogen effect appears to be direct and at the gene transcription level since it did not alter the stability of RARa mRNA and cycloheximide failed to block estrogen-mediated enhancement of RARa gene expression. Our data strongly suggest that ER-mediated enhancement of RARa levels plays an important role in RA inhibition of HBC growth. In addition, we also report here that HBC cells appear to express a unique isoform(s) of RARa which was detected only when the full-length RARa cDNA was used as a probe; the RARaI and RARa2 specific probes failed to hybridize with the HBC specific RARa message.